TITLE

Fibroblast Growth Factor 23, Parathyroid Hormone, and 1α, 25-Dihydroxyvitamin D in Surgically Treated Primary Hyperparathyroidism

AUTHOR(S)
Tebben, Peter J.; Singh, Ravindern J.; Clarke, Bart L.; Kumar, Rajiv
PUB. DATE
December 2004
SOURCE
Mayo Clinic Proceedings;Dec2004, Vol. 79 Issue 12, p1508
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
OBJECTIVE: To determine whether fibroblast growth factor 23 (FGF23) contributes to the hypophosphatemia of primary hyperparathyroidism. PATIENTS AND METHODS: Thirteen adult patients with primary hyperparathyroidism had serum collected before and after parathyroidectomy for analysis of inorganic phosphorus, calcium, 1α,25-dihydroxyvitamin D (1α,25[OH]2D), parathyroid hormone (PTH), FGF23, creatinine, and bone-specific alkaline phosphatase (BSAP). Patients were recruited between July 24, 2003, and February 11, 2004. RESULTS: Before surgery, patients had elevated serum calcium and PTH concentrations. Serum phosphorus concentration were in the low-normal range. The FGF23 concentrations were not elevated in patients with primary hyperparathyroidism compared with healthy controls. Within 24 hours of surgery, serum calcium, PTH, 1α,25(OH)2D, and BSAP concentrations were lower (P<.002 for all) and phosphorous concentrations were higher (P=.003) than in the preoperative state. The FGF23 concentrations were similar 1 day and 6 weeks after surgery. The FGF23 concentrations did not correlate with serum phosphorus, calcium PTH, 1α,25(OH)2D, creatinine, or BSAP concentrations in the preoperative or postoperative state. CONCLUSION: Parathyroid hormone is the major regulator of serum phosphorus concentrations in patients with primary hyperparathyroidism. Fibroblast growth factor 23 does not appear to play a role in phosphorus homeostatis in patients with surgically treated primary hyperparathyroidism.
ACCESSION #
15323736

 

Related Articles

  • Secondary Hyperparathyroidism Disease Stabilization Following Calcimimetic Therapy. Frazão, João; Rodriguez, Mariano // NDT Plus;Jan2008 Supplement 1, Vol. 1, pi12 

    Standard therapy for secondary hyperparathyroidism (SHPT) includes dietary calcium supplementation, active vitamin D, and phosphate binders; however, these are often insufficient to allow patients to achieve their serum parathyroid hormone (PTH), calcium and calcium–phosphorus product (Ca...

  • Vitamin D and Bone Mineral Density in Ambulatory Women Living in Buenos Aires, Argentina. Fradinger, E. E.; Zanchetta, J. R. // Osteoporosis International;Feb2001, Vol. 12 Issue 1, p24 

    : The aim of this study was to determine possible associations between bone mineral density (BMD), 25-hydroxyvitamin D (25(OH)D) and intact parathyroid hormone (PTH). In a retrospective study we examined the case notes of free-living postmenopausal women living in our city (34° S). We also...

  • Contrasting mammalian PTH promoters: identification of transcription factors controlling PTH gene expression. Koszewski, N. J.; Alimov, A. P.; Langub, M. C.; Park-Sarge, O.-K.; Malluche, H. H. // Clinical Nephrology;2005, Vol. 63 Issue 2, p158 

    Parathyroid hormone (PTH) is a key component in the maintenance of calcium and phosphate homeostasis. The steady-state expression of the PTH gene can be modeled as a balance between transcriptional activators and repressors. During renal failure, the gradual loss of kidney function is of ten...

  • Effects of calcitriol and non-calcemic vitamin D analogs on secondary hyperparathyroidism. Slatopolsky, Eduardo; Berkoben, Michael; Kelber, Jacobo; Brown, Alex; Delmez, James // Kidney International Supplement;Oct1992, Issue 38, pS-43 

    Describes the effects of calcitriol and non-calcemic vitamin D analogs on secondary hyperparathyroidism. Role of ionized calcium and calcitroil in parathyroid hormone synthesis and secretion; Potential function of non-calcemic analogs of vitamin D in skin cells; Significance of the findings of...

  • hyperparathyroidism. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p395 

    An encyclopedia entry for "hyperparathyroidism" is presented. It refers to the overproduction of parathyroid hormone (PTH) by the parathyroid glands. PTH normally works with vitamin D and another hormone called calcitonin in controlling the level of calcium in the blood by removing calcium from...

  • FGF-23 and vitamin D: don't shoot the messenger? Fish, Richard S.; Cunningham, John // Nephrology Dialysis Transplantation;Jun2012, Vol. 27 Issue 6, p2137 

    The discovery of fibroblast growth factor-23 (FGF-23) as a key regulator of phosphate and vitamin D metabolism has forced a rethink about the mineral and bone disorder of chronic kidney disease (CKD). FGF-23 powerfully predicts adverse cardiovascular outcomes in patients with CKD and an...

  • Parathyroid diseases and animal models. Imanishi, Yasuo; Nagata, Yuki; Inaba, Masaaki // Frontiers in Endocrinology;May2012, preceding p1 

    Circulating calcium and phosphate are tightly regulated by 3 hormones: the active form of vitamin D (1,25-dihydroxyvitamin D), fibroblast growth factor (FGF)-23, and parathyroid hormone (PTH). PTH acts to stimulate a rapid increment in serum calcium and has a crucial role in calcium homeostasis....

  • Post-transplant hypophosphatemia: Tertiary ‘Hyper-Phosphatoninism’? Bhan, I.; Shah, A.; Holmes, J.; Isakova, T.; Gutierrez, O.; Burnett, S.-A.; Jüppner, H.; Wolf, M. // Kidney International;Oct2006, Vol. 70 Issue 8, p1486 

    Hypophosphatemia is a common complication of kidney transplantation. Tertiary hyperparathyroidism has long been thought to be the etiology, but hypophosphatemia can occur despite low parathyroid hormone (PTH) levels and can persist after high PTH levels normalize. Furthermore, even in the...

  • Calcium Metabolism & Hypercalcemia in Adults. Lumachi, F.; Motta, R.; Cecchin, D.; Ave, S.; Camozzi, V.; Basso, S. M. M.; Luisetto, G. // Current Medicinal Chemistry;Aug2011, Vol. 18 Issue 23, p3529 

    Calcium is essential for many metabolic process, including nerve function, muscle contraction, and blood clotting. The metabolic pathways that contribute to maintain serum calcium levels are bone remodeling processes, intestinal absorption and secretion, and renal handling, but hypercalcemia...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics